The underlying diagnoses were MCADD (3), VLCADD (1), MADD (2), long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) (1), carnitine palmitoyltransferase II (CPT2) deficiency (2), carnitine-acylcarnitine translocase (CACT) deficiency (1), and HLCSD (1) (Table 2). This evidence concerns the gene SLC25A20 and carnitine-acylcarnitine translocase deficiency.